SPI1 and steatosis: Adipocyte specific KO of PU.1 resulted in decreased liver inflammation, decreased steatosis and significantly improved liver insulin sensitivity compared with fl/fl controls, as revealed by both hyperinsulinemic-euglycemic clamp and acute insulin signaling studies.